SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Revenue reduced marginally to stand at Rs. 15880.00 millions during the quarter ended December 2021. The figure stood at Rs. 16160.00 millions during the year-ago period.Net profit of the cmpany stood at Rs. 1700.00 millions for the quarter ended December 2021 a decline of -38.85% from Rs. 2780.00 millions  in the same quarter last year.Operating Profit reported a sharp decline to 4640.00 millions from 5810.00 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 15880.00 16160.00 -1.73 50820.00 49830.00 1.99 64510.00 61680.00 4.59
Other Income 370.00 110.00 236.36 1410.00 270.00 422.22 1180.00 2370.00 -50.21
PBIDT 4640.00 5810.00 -20.14 17630.00 17930.00 -1.67 23150.00 21540.00 7.47
Interest 570.00 870.00 -34.48 1870.00 2700.00 -30.74 3390.00 4300.00 -21.16
PBDT 4070.00 4940.00 -17.61 15760.00 15230.00 3.48 19760.00 17240.00 14.62
Depreciation 1520.00 1550.00 -1.94 4550.00 4580.00 -0.66 6100.00 6070.00 0.49
PBT 2550.00 3390.00 -24.78 11210.00 10650.00 5.26 13660.00 11170.00 22.29
TAX 850.00 610.00 39.34 3510.00 2060.00 70.39 2280.00 1780.00 28.09
Deferred Tax 400.00 10.00 3900.00 1550.00 190.00 715.79 -200.00 -140.00 42.86
PAT 1700.00 2780.00 -38.85 7700.00 8590.00 -10.36 11380.00 9390.00 21.19
Equity 846.20 846.20 0.00 846.20 846.20 0.00 846.20 846.20 0.00
PBIDTM(%) 29.22 35.95 -18.73 34.69 35.98 -3.59 35.89 34.92 2.76

Torrent Pharma Share Price

4178.85 22.50 (0.54%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×